NURIX THERAPEUTICS, INC. (NRIX) /
The profitability of NURIX THERAPEUTICS, INC. over the past 7 years
Chart NURIX THERAPEUTICS, INC.: operating income, net income, fiscal 2019–2025 Open the chart →NURIX THERAPEUTICS, INC. reported a net loss of $264.46M in fiscal 2025, the latest fiscal year on file. That year it had an operating loss of $285.67M. It reported a loss in all 7 years shown.
Year by year
| Fiscal year | Operating income | Net income |
|---|---|---|
| 2025ended Nov 30, 2025 | -$285.67M | -$264.46M |
| 2024ended Nov 30, 2024 | -$213.03M | -$193.57M |
| 2023ended Nov 30, 2023 | -$155.06M | -$143.95M |
| 2022ended Nov 30, 2022 | -$183.87M | -$180.36M |
| 2021ended Nov 30, 2021 | -$117.89M | -$117.19M |
| 2020ended Nov 30, 2020 | -$64.98M | -$43.24M |
| 2019ended Nov 30, 2019 | -$22.24M | -$21.7M |
Fiscal years as NURIX THERAPEUTICS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on NURIX THERAPEUTICS, INC.
- The revenue of NURIX THERAPEUTICS, INC.
- The cash flow of NURIX THERAPEUTICS, INC.
- The debt of NURIX THERAPEUTICS, INC.
- All of NURIX THERAPEUTICS, INC.'s financials, charted
Companies of a similar size
- UNFIUnited Natural Foods, Inc.
- DANDana Incorporated
- FLYFirefly Aerospace Inc.
- PTRNPattern Group Inc.
- CUBICustomers Bancorp, Inc.
Not investment advice. This page shows what NURIX THERAPEUTICS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.